Is Intertek Group profitable in 2025?

Yes. Intertek reported FY2025 group revenue of £3,431.6m, operating profit of £619.6m (18.1% operating margin, up 90bps year on year), and net income of £363.2m, as of 31 December 2025, with cash conversion around 110%.

Who owns Intertek now, is it being taken private?

Intertek's board agreed a recommended cash takeover by EQT's vehicle Isotope Bidco Limited on 18 June 2026, at up to £61.077 per share including a retained dividend. The Scheme Document was sent to shareholders 15 July 2026, with a long-stop completion date of 18 June 2027.

Could AI replace Intertek's testing and certification business?

Unlikely soon. Intertek holds accreditation and notified-body legal standing that AI tools cannot obtain, and on 24 June 2025 it launched Intertek AI², an end-to-end AI assurance program including ISO 42001 certification, positioning itself to certify AI systems rather than be displaced by them.

Who is Intertek's biggest competitor?

SGS of Switzerland is the world's largest testing, inspection and certification firm with about 100,000 employees and 2,500+ offices in 115+ countries, versus Intertek's 45,425 employees as of 31 December 2025. Bureau Veritas (~$7.84bn revenue) and Eurofins also compete closely.

Is Intertek splitting into separate companies?

Intertek launched a Strategic Review on 14 April 2026 into a possible sale or demerger of its Energy & Infrastructure division (~£1.6bn 2025 revenue) from Testing & Assurance (~£1.9bn 2025 revenue); the outcome under incoming EQT ownership remains unresolved as of mid 2026.

How much did EQT offer to buy Intertek?

EQT's proposals escalated from £51.50, £54.00 to £58.00 per share in early May 2026, all rejected, before a final agreed offer of £60.00 per share cash plus the retained FY25 dividend, worth up to £61.077 per share, versus a pre-bid price of £37.70 on 9 April 2026.

Biotech tools companies · acquisition pending · United Kingdom

Intertek Group plc

intertek.com ↗

UK-based testing, inspection, and certification firm for global industries.

Hard to displace

Assessed 24 July 2026 · Evidence as of 24 July 2026

Strong structural protection; the business model survives ai pressure.

On the recordSince 24 July 2026 · Checkable from June 2027 · Every call on the record Checkpoint: Long-stop date for EQT take-private scheme (shareholder votes, court sanction, regulatory clearances)

The call

A profitable, accredited testing network facing a private equity buyout and an unresolved split of its energy business, not an AI takeover.

Intertek is a company that tests, inspects, and certifies products for safety and quality across industries like energy, consumer goods, and manufacturing. It is hard to copy because regulators require their specific approvals, companies need their lab network in hundreds of locations, and liability rules lock in their role. The main threat is that AI tools could make some routine testing faster and cheaper, but Intertek is already selling AI certification services to stay ahead of that shift. Watch whether the company's new AI business line grows fast enough to offset declining margins in basic testing as AI spreads through the industry, and whether the planned private buyout by EQT goes through as planned.

Why

AI pressure: AI-driven visual inspection tools (e.g. Landing AI). AI vision tools could automate routine factory checks, but accredited certification still needs a human, liable signature. Could AI do the core job? Unlikely.

Bigger players: Bureau Veritas SA. Bureau Veritas runs a similar global accredited lab network and competes for the same enterprise testing contracts today. Could a giant copy it? No, they are blocked.

What protects it. Accreditations, notified-body status, and a 1,000+ lab network give it legal standing no AI tool or new entrant can copy quickly.

What would change this call

EQT take-private vote/regulatory clearance/court sanction outcome by the June 2027 long-stop. Shows whether the buyout completes or Intertek stays public and independent.
Decision on Energy & Infrastructure division sale or demerger under EQT. Shows whether the core testing/certification franchise is being reshaped or destabilized.
Reported growth in Intertek AI2 certification revenue in future results. Shows whether Intertek is monetising AI-driven testing demand or losing share to it.

Key numbers

FY2025 revenue £3,431.6m, up 4.3% at constant currency (2025-12-31)
Operating margin 18.1%, up 90bps year on year (2025-12-31)
Cash conversion around 110%, op. cash flow £762m (2025-12-31)

Named risks

EQT take-private deal could fail to complete by long-stop date 18 June 2027. Severity: medium
Strategic Review splitting Energy & Infrastructure from Testing & Assurance could destabilize core franchise. Severity: medium
World of Energy generates 21% of revenue but only 10% of operating profit, a margin drag. Severity: medium
Historical reputational incidents: 2000 US data-falsification scandal and 2023 dismissal of ex-SAI Global auditors. Severity: low
Post-close EQT leverage or cost-cutting could erode lab and accreditation capex over time. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
SGS	contesting	SGS ~100,000 employees vs Intertek 45,425 as of 2025-12-31, per aventis-advisors 2026-06-03
Bureau Veritas	contesting	Bureau Veritas ~$7.84bn revenue and 84,000 employees, comparable scale to Intertek's £3.43bn FY25
Eurofins Scientific	contesting	Overlaps Intertek's health and safety and life-sciences-adjacent testing lines, per TIC market report 2026-03-31
DEKRA	contesting	Named among top five TIC firms holding ~11.7% combined global share, per gminsights 2026-03-31

Questions people ask

Is Intertek Group profitable in 2025?: Yes. Intertek reported FY2025 group revenue of £3,431.6m, operating profit of £619.6m (18.1% operating margin, up 90bps year on year), and net income of £363.2m, as of 31 December 2025, with cash conversion around 110%.
Who owns Intertek now, is it being taken private?: Intertek's board agreed a recommended cash takeover by EQT's vehicle Isotope Bidco Limited on 18 June 2026, at up to £61.077 per share including a retained dividend. The Scheme Document was sent to shareholders 15 July 2026, with a long-stop completion date of 18 June 2027.
Could AI replace Intertek's testing and certification business?: Unlikely soon. Intertek holds accreditation and notified-body legal standing that AI tools cannot obtain, and on 24 June 2025 it launched Intertek AI², an end-to-end AI assurance program including ISO 42001 certification, positioning itself to certify AI systems rather than be displaced by them.
Who is Intertek's biggest competitor?: SGS of Switzerland is the world's largest testing, inspection and certification firm with about 100,000 employees and 2,500+ offices in 115+ countries, versus Intertek's 45,425 employees as of 31 December 2025. Bureau Veritas (~$7.84bn revenue) and Eurofins also compete closely.
Is Intertek splitting into separate companies?: Intertek launched a Strategic Review on 14 April 2026 into a possible sale or demerger of its Energy & Infrastructure division (~£1.6bn 2025 revenue) from Testing & Assurance (~£1.9bn 2025 revenue); the outcome under incoming EQT ownership remains unresolved as of mid 2026.
How much did EQT offer to buy Intertek?: EQT's proposals escalated from £51.50, £54.00 to £58.00 per share in early May 2026, all rejected, before a final agreed offer of £60.00 per share cash plus the retained FY25 dividend, worth up to £61.077 per share, versus a pre-bid price of £37.70 on 9 April 2026.

Timeline

2026-07-23Co-investors update: Mubadala, PSP, APG, Lunate hold ~25.9% of Bidco; market cap ~£8.93bn
2026-07-15Scheme Document for EQT takeover sent to Intertek shareholders
2026-06-18Boards agree recommended cash acquisition by EQT's Isotope Bidco Limited
2026-05-12EQT final proposal reaches up to £61.077 per share including dividend
2026-05-05EQT makes escalating unsolicited proposals £51.50 to £58.00 per share, rejected
2026-04-14Strategic Review launched into separating Energy & Infrastructure; Q1 LFL growth 5.4%
2025-12-31FY2025 results: revenue £3,431.6m, operating margin 18.1%, 45,425 employees
2025-06-24Intertek AI² AI assurance program launched

Revision history

24 July 2026

First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.

In the same band

Merck KGaA (MilliporeSigma)Eurofins Scientific SE Carl Zeiss AG